Sorbitol for Health & Longevity

Created on 11/06/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Opus 5.5 – Audit

Sorbitol, a sugar alcohol in fruit, sugar-free products and medicines, is also an inexpensive laxative. In older adults it eased constipation about as well as a costlier option; no study compared it with a placebo. Teeth and blood-glucose gains mainly reflect replacing sugar; chewing apparently drives most dental gains. Bloating, gas and diarrhea rise with dose; inherited fructose intolerance makes it dangerous. Longevity links rest on worm studies alone. (Full Review)

Protocol

Laxative regimen (trial)
0–60 mL of 70% solution daily
Dose adjusted to response for chronic constipation in older men
Laxative regimen (prescribing information)
30–150 mL of 70% solution
Oral single dose for constipation
Sweetener use
Below 10 g per sitting
Under the 50 g daily labeling threshold; spread across meals
Time to effect
Laxative onset
1–3 hours
Loose stools after a 40 g dose
Constipation response
4 weeks
Assessment period in constipation trials
Caries effects
2–3 years
Accrued in a sorbitol gum trial

Benefits

Contraindications
  • Hereditary fructose intolerance: absolute contraindication
  • Anuria
  • People receiving sodium polystyrene sulfonate
  • Biallelic SORD variants: inferred, no human data on dietary sorbitol
  • IBS with sorbitol confirmed as a personal trigger
  • Suspected bowel obstruction: inferred, no sorbitol-specific human data
Key Interactions
  • Oral drug solutions (ranitidine, lamivudine, risperidone): lower drug blood levels
  • Metoprolol: lower peak concentration
  • Cimetidine: findings conflict on absorption
  • Theophylline (slow-release): lower blood levels
  • Activated charcoal (repeated doses): severe high blood sodium
  • Other polyols (xylitol, mannitol): more malabsorption in combination
  • Fructose and fructose-rich foods: combined malabsorption and distress
  • Sorbitol-containing liquid medicines (syrups, elixirs): cumulative laxative doses
Theoretical (inferred from mechanism)
  • Other osmotic laxatives (lactulose, polyethylene glycol 3350): may cause diarrhea and dehydration
  • Fermentable fibers (inulin): may increase bloating and flatulence
  • High-dose magnesium or vitamin C supplements (magnesium citrate, ascorbic acid above 2 g): may cause diarrhea
  • Diuretics (furosemide, hydrochlorothiazide): may cause dehydration or low blood potassium
  • Lithium: may raise lithium levels and toxicity risk
  • Antidiarrheals (loperamide): may mask diarrhea or blunt the laxative effect

Risk & Side Effects

  • High: Dose-dependent gastrointestinal symptoms
  • Medium:
  • Low: Weight loss from chronic hidden intake; serious reactions in hereditary fructose intolerance; colonic necrosis with potassium-binding resin; fluid and electrolyte loss at laxative doses; raised blood glucose in diabetes; coronary heart disease association with plasma polyols
  • Speculative: Liver fat; cognitive decline

Monitoring

Marker Target Why
Body weight No established target; track change from own baseline Unexplained loss signals chronic diarrhea
Serum sodium 135–145 mmol/L Rises with dehydration at laxative doses
Serum potassium 3.5–5.0 mmol/L Falls with sustained diarrhea
HbA1c 4.0–5.6% May fall when sorbitol displaces sugar
Sorbitol hydrogen breath test Rise under 20 ppm over baseline Identifies people prone to symptoms

Cadence: Baseline before deliberate or laxative-dose use; symptom and stool review at 1 and 4 weeks; electrolytes after 2–4 weeks of repeated laxative-dose use; weight and HbA1c every 6–12 months for habitual sweetener use

Qualitative Assessment

  • Stool frequency and form
  • Bloating, flatulence and cramping
  • Urgency or nighttime bowel movements
  • New caries at dental check-ups